Leadership
GBM AGILE
About GBM AGILE
GBM AGILE Trial Sites
FAQs
Strategic Partners
REMAP-COVID
About REMAP-COVID
News
Join Us
Contact
DONATE
< Back to News
Kazia Executes Agreement to Commence GBM AGILE Pivotal Study
OCTOBER 16, 2020 | Kazia Therapeutics
https://kza.irmau.com/irm/PDF/4d179643-5c71-45df-9721-e521cedd4798/KaziaexecutesGBMAgilestudyagreement
Home
Leadership
About REMAP-COVID
GBM AGILE
About GBM AGILE
GBM AGILE Trial Sites
FAQs
Strategic Partners
News
Join Us
Contact
DONATE